Arndt Hartmann
Friedrich-Alexander-Universität Erlangen-Nürnberg(DE)Universitätsklinikum Erlangen(DE)Max Planck Institute for Chemistry(DE)Hartmann Group (Germany)(DE)Comprehensive Cancer Center Erlangen(DE)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Cancer Genomics and Diagnostics, Urinary and Genital Oncology Studies, Genetic factors in colorectal cancer, Epigenetics and DNA Methylation
Most-Cited Works
- → Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies(2010)714 cited
- → Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis(2005)407 cited
- → WIF1, a component of the Wnt pathway, is down‐regulated in prostate, breast, lung, and bladder cancer(2003)333 cited
- → A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease(2003)208 cited
- → EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†(2019)190 cited
- → EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees